Peijia Medical Executive and Leadership Team

Michael Zhang, the Chairman & Chief Executive Officer at Peijia Medical, directs the overarching corporate strategy and vision. Zhang guides the company's expansion into high-end medical devices, specifically targeting structural heart disease and neurovascular interventions. This leadership role involves setting the direction for product development and market penetration, ensuring alignment with the mission to improve patient quality of life. Overseeing global operations, Michael Zhang ensures the company's comprehensive range of products, including aortic, mitral, and tricuspid valves, alongside surgical accessories and neurovascular intervention products, meet rigorous safety and efficacy standards. The Chairman & Chief Executive Officer fosters a culture of continuous innovation, driving the development of accessible solutions for hospitals and healthcare providers worldwide. Zhang's strategic oversight is critical for maintaining Peijia Medical's position as a global provider of innovative medical solutions.

Leo Tsai, the Chief Financial Officer at Peijia Medical, manages all financial operations and strategic financial planning. Tsai oversees budgeting, forecasting, and capital allocation to support the company's growth in innovative medical devices for structural heart disease and neurovascular interventions. This executive function ensures the financial health and sustainability of Peijia Medical's global operations. The Chief Financial Officer directs treasury functions, manages investor relations, and ensures compliance with all financial regulations across the company's markets. Leo Tsai's expertise is vital in securing funding for research and development, enabling the continuous innovation that defines Peijia Medical's product offerings. By optimizing financial resources, Tsai supports the delivery of safe, effective, and accessible solutions aimed at enhancing patient quality of life for cardiovascular and neurovascular disease patients.

Karl Pan, the Chief Operating Officer at Peijia Medical, directs the execution of operational strategies across manufacturing and supply chain functions. Pan ensures the efficient production and delivery of high-end medical devices, including those for structural heart disease and neurovascular interventions, meeting global demand. This executive position is key to maintaining the quality and accessibility of Peijia Medical's comprehensive product range. The Chief Operating Officer oversees global manufacturing facilities and logistics, optimizing processes to support continuous innovation and product development. Karl Pan's operational leadership guarantees that hospitals and healthcare providers receive safe and effective solutions reliably. By streamlining operations, Pan directly contributes to improving patient quality of life through timely access to advanced medical technologies.

JianFong Tan, the Chief Technology Officer at Peijia Medical, architects the technological roadmap for innovative medical products. Tan leads research and development efforts focused on high-end medical devices within structural heart disease and neurovascular interventions. This critical role ensures Peijia Medical remains at the forefront of technological advancement in cardiovascular and neurovascular solutions. The Chief Technology Officer oversees the integration of cutting-edge technologies into product lines, including advanced valves and intervention tools, driving the company's commitment to continuous innovation. JianFong Tan's technical leadership is instrumental in developing safe, effective, and accessible solutions that directly improve patient outcomes and quality of life. Tan's focus on technological excellence supports the company's mission to provide superior medical devices to hospitals and healthcare providers globally.